Salem M G, Richardson J C, Meadows G A, Lamplugh G, Lai K M
Br J Anaesth. 1985 Feb;57(2):184-7. doi: 10.1093/bja/57.2.184.
Atropine and glycopyrrolate were compared in a mixture with neostigmine for reversal of neuromuscular blockade in patients undergoing open heart surgery. In patients not receiving beta-blocking drugs, glycopyrrolate was shown to possess advantages over atropine in terms of a lower initial increase in heart rate, better protection against the muscarinic effects of neostigmine, and smaller increases in rate-pressure product. The concomitant administration of beta-adrenergic blocking therapy significantly attenuated the effect of reversal on heart rate and the differences between atropine and glycopyrrolate were not significant. There was no difference in the incidence of arrhythmias between patients who received beta-blocking drugs and those who did not.
在接受心脏直视手术的患者中,对阿托品和格隆溴铵与新斯的明混合使用以逆转神经肌肉阻滞的效果进行了比较。在未接受β受体阻滞剂的患者中,就心率的初始增幅较低、对新斯的明毒蕈碱样作用的保护更好以及心率-血压乘积的增幅较小而言,格隆溴铵显示出优于阿托品的优势。β肾上腺素能阻滞剂疗法的同时使用显著减弱了逆转对心率的影响,阿托品和格隆溴铵之间的差异不显著。接受β受体阻滞剂的患者与未接受β受体阻滞剂的患者心律失常的发生率没有差异。